KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Curent Deferred Tax Liability Curent Deferred Tax Liability Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Deferred Tax Assets Current Leases Current Taxes Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

Labcorp Holdings (LH) Liabilities from Discontinued Operations (2017 - 2022)

Labcorp Holdings' Liabilities from Discontinued Operations history spans 2 years, with the latest figure at 657600000.0 for Q4 2022.

On a quarterly basis, Liabilities from Discontinued Operations changed N/A to 657600000.0 in Q4 2022 year-over-year; TTM through Dec 2022 was 657600000.0, a N/A change, with the full-year FY2022 number at 657600000.0, changed N/A from a year prior.
Liabilities from Discontinued Operations hit 657600000.0 in Q4 2022 for Labcorp Holdings, roughly flat from 657600000.0 in the prior quarter.
Over the last five years, Liabilities from Discontinued Operations for LH hit a ceiling of 657600000.0 in Q2 2022 and a floor of 657600000.0 in Q2 2022.